Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2002
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002WO2001058855A9 Use of androgen receptor suppressors
10/31/2002WO2001056563A9 Adamantyl derivatives as anti-cancer agents
10/31/2002US20020161266 Performing a one-pot organic reaction, which includes carbon monoxide (CO) as reactant and does not use of an external gas source, by contacting a non-catalyzing CO releasing compound such as a metal carbonyl with an energy source
10/31/2002US20020161261 Ionic liquids and production and use thereof
10/31/2002US20020161252 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine))
10/31/2002US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002US20020161041 Resorcinol derivatives
10/31/2002US20020161007 Non-steroidal modulators of estrogen receptors
10/31/2002US20020160987 Novel 4-dedimethylaminotetracycline derivatives
10/31/2002US20020160501 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
10/31/2002CA2439959A1 A method for the preparation of oxazolidinones
10/30/2002EP1252166A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them
10/30/2002EP1252152A1 Urea compounds as inhibitors for vla-4
10/30/2002EP1252151A1 A process for the preparation of quetiapine and intermediates therefor
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1105368B1 Photoactivatable bases containing nitrogen
10/30/2002EP0852225B1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
10/30/2002CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/30/2002CN1376664A Propynyl or diene diaryl compounds
10/29/2002US6472531 Single reaction vessel acylation and deetherification production of crystalline, high purity chemical intermediates for such as pharmaceuticals
10/29/2002US6472415 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
10/29/2002US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002US6472364 Detergent compositions or components
10/29/2002CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/25/2002CA2383175A1 Methods and kits for treating depression or preventing deterioration of cognitive function
10/24/2002WO2002083842A2 Small molecule inhibitors of secretion of proteins encoded by are-mrnas
10/24/2002WO2002083658A1 Piperazine-benzamide derivatives useful as apob-100 and/or mtp inhibitor
10/24/2002WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002WO2002066451A3 1,2-diphenyl-1-naphthyl ethene derivatives, analogs and use thereof
10/24/2002WO2002066428A3 Non-steroidal estrogen receptor ligands
10/24/2002WO2002038540A3 Activity-dependent cysteine protease profiling reagent
10/24/2002US20020156314 Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
10/24/2002US20020156311 Glucocorticoid receptor modulators
10/24/2002US20020156295 Coordination catalyst containing ligand
10/24/2002US20020156228 (poly)ether amine ester isocyanate derivatives that can be reacted with hydroxy and amino compounds to form urethanes or ureas used in the isolation of nucleic acids
10/24/2002US20020156107 Amino ceramide - like compounds and therapeutic methods of use
10/24/2002US20020156090 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
10/24/2002US20020156077 Antiproliferative agents against estrogen-dependent cancer cells dibenzothiopyran, dibenzopyran and phenanthrene derivatives
10/24/2002US20020156075 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
10/24/2002US20020156018 Treating parasitic diseases, which are mediated by such proteases. In particular, treating malaria by inhibiting the cysteine protease falcipain.
10/24/2002CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002CA2444264A1 Prodrugs via acylation with cinnamate
10/23/2002EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002EP1250317A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
10/23/2002CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002CN1093125C Sulfamide-metalloprotease inhibitors
10/23/2002CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/22/2002US6469211 Hydrogenation of nitriles over Raney catalysts
10/22/2002US6469193 Efficient synthesis of alkyl carbonates
10/22/2002US6469168 For the treatment of central nervous system disorders, especially anxiety
10/22/2002US6469047 Tyrosine derivatives
10/22/2002US6469011 Benzenesulfonamide compounds useful as TXA2 and 5-HT2 receptor antagonists
10/22/2002US6469010 Medicament for the alleviation or treatment of symptom derived from the ischemic disease and compound useful thereof
10/22/2002US6468753 Anthraquinone and its derivatives
10/22/2002US6468502 Paramagnetic macromolecules with higher proton relaxivity; lower dosage and increased signal intensity; detecting vascular diseases; differentiating tissue blood supply levels; distinguishing myocardial infarction from ischemia
10/17/2002WO2002081460A1 Lipid lowering biphenylcarboxamides
10/17/2002WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002WO2002081433A1 Sulphones which modulate the action of gamma secretase
10/17/2002WO2002057261A3 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
10/17/2002WO2002048164A3 Isolation of nucleic acids
10/17/2002US20020151595 Carboxylic acid amides having antithrombotic activity
10/17/2002US20020151586 Antidiabetic agents
10/17/2002US20020151554 Cyclin-dependent kinase inhibitors such as (4-Amino-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-thiazolyl) (2,3-dihydro-1,4-benzodioxin-6-yl)methanone for treatment of breast, lung, colon, and prostate cancer/tumors
10/17/2002US20020151552 Novel compounds
10/17/2002US20020151547 Substituted phenyl-piperidine methanone compounds
10/17/2002US20020151546 HIV protease inhibitors based on amino acid derivatives
10/17/2002US20020151539 Novel heterocyclic compounds
10/17/2002US20020151534 Antithrombotic compounds
10/17/2002US20020150961 Activity-dependent cysteine protease profiling reagent
10/17/2002US20020148052 Such as 4-amino-2-(2-dimethylamino-ethyl)-phenol; useful in place of p-aminophenol
10/16/2002EP1249245A1 Remedies and/or preventives for nervous system disorders
10/16/2002EP1249233A1 Npyy5 antagonists
10/16/2002EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002EP1248607A1 Urotensin-ii receptor antagonists
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002CN1375058A Method and device for detecting and insolating pharmacological compounds being contained in substance mixtures
10/16/2002CN1374956A 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof and their use as anticonvulsants
10/16/2002CN1374954A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds
10/16/2002CN1374076A hair cosmetics, aminocarboxylic acid amide and its producing process
10/15/2002US6465684 Process for the separation of a mixture of enantiomers
10/15/2002US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002US6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides
10/15/2002US6465455 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/15/2002US6465433 Boronic ester and acid compounds, synthesis and uses
10/10/2002WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002079691A1 Materials, methods, and uses for photochemical generation of acids and/or radical species
10/10/2002WO2002079160A1 A process for the synthesis of an aliphatic cyclic amine
10/10/2002WO2002079145A1 BENZAMIDE INHIBITORS OF FACTOR Xa
10/10/2002WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002WO2002079137A1 Interleukin-1 and tumor necrosis factor-alpha modulators and their enantiomers, their synthesis and use
10/10/2002WO2002078744A1 Remedies for psychoneurosis
10/10/2002WO2002062763A3 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 341